Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902 - Concepedia

Concepedia

Publication | Closed Access

Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902

39

Citations

18

References

2006

Year

Caio Rocha‐Lima, James E. Herndon, Mi-Ji Lee, J. N. Atkins, Ann M. Mauer, Everett E. Vokes, M. R. Green

Annals of Oncology

Phase Ii TrialMedicineMetronomic TherapyPharmacologyPharmacotherapyCancer TreatmentSecond-line TherapyOncologyLung Cancer

References

	Year	Citations

Page 1